The initial public offering (IPO) of LargeV Instrument Corp., Ltd to the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR) has been suspended for review, following the withdrawal of the filing and sponsorship. The Beijing-based company, which specializes in the research and development (R&D), manufacturing, and marketing of medical cone-shaped beam CT systems and accompanying software, initially had its filing accepted for review on June 29, 2022. It subsequently received its first round of inquiry on July 20, 2022, to which LargeV responded.
In 2021, LargeV reported revenues of RMB 405 million and invested RMB 36.29 million in R&D, indicating the company’s commitment to innovation in the high end medical equipment field.-Fineline Info & Tech
